Mike Polark
Stock Analyst at Baird
(2.14)
# 2,822
Out of 5,182 analysts
87
Total ratings
40.35%
Success rate
-2.22%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $125.32 | +59.59% | 14 | Feb 20, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Peer Perform | n/a | $57.59 | - | 11 | Feb 13, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $47.64 | -1.34% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $80.99 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $86.19 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $12.98 | +54.08% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $67.12 | -10.61% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $203.73 | +71.80% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $22.81 | +27.14% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $228.12 | -21.09% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $94.78 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $343.32 | +17.97% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $469.21 | +7.20% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $96.81 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $131.58 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $63.98 | +89.12% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $20.61 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $16.30 | +53.37% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $178.39 | -7.51% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $64.23 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $16.20 | -19.75% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $3.29 | +538.30% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $225.79 | +10.72% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $0.92 | +4,573.91% | 1 | Sep 2, 2020 |
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $125.32
Upside: +59.59%
Inspire Medical Systems
Feb 13, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $57.59
Upside: -
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $47.64
Upside: -1.34%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $80.99
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $86.19
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $12.98
Upside: +54.08%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $67.12
Upside: -10.61%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $203.73
Upside: +71.80%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $22.81
Upside: +27.14%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $228.12
Upside: -21.09%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $94.78
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $343.32
Upside: +17.97%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $469.21
Upside: +7.20%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $96.81
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $131.58
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $63.98
Upside: +89.12%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $20.61
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $16.30
Upside: +53.37%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $178.39
Upside: -7.51%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $64.23
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $16.20
Upside: -19.75%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $3.29
Upside: +538.30%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $225.79
Upside: +10.72%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $0.92
Upside: +4,573.91%